4.5 Article

A Micro-computed Tomography Evaluation of the Shaping Ability of Two Nickel-titanium Instruments, HyFlex EDM and ProTaper Next

Journal

JOURNAL OF ENDODONTICS
Volume 43, Issue 4, Pages 628-632

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.joen.2016.11.022

Keywords

Centering ratio; controlled memory; HyFlex EDM; M-wire; microcomputed tomography; ProTaper Next; root canal preparation; transportation

Funding

  1. Coltene/Whaledent

Ask authors/readers for more resources

Introduction: The aim of this study was to evaluate and compare, by means of micro computed tomography imaging, the shaping ability of ProTaper Next (PTN) and the novel HyFlex EDM (HFEDM) instruments. Methods: Forty teeth were randomly divided into 2 groups and prepared with PTN or HFEDM. Root canal transportation and centering ratio were evaluated in mesiodistal and buccolingual directions at 5 levels (at the midpoint of the apical, middle, and coronal thirds and at the boundaries between them). Variations in volume, surface, and cross-sectional shape were measured for the apical, middle, and coronal thirds. The null hypotheses were that no differences existed between the 2 groups. The D'Agostino-Pearson test (alpha = .05) was conducted to assess the normality of the data sets. The distributions were compared by using the Mann-Whitney test (alpha = .05). Results: Statistically significant differences (P < .005) were recorded only for buccolingual canal transportation and centering ratio at the section between the middle and coronal thirds, where HFEDM files were superior. Conclusions: HFEDM and PTN files were similarly effective, and both safely prepared the root canals, respecting their original anatomies. HFEDM files performed better in terms of buccolingual canal transportation and centering ratio at the section between the middle and coronal thirds.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients

Michele Correale, Olga Lamacchia, Michele Ciccarelli, Giuseppe Dattilo, Lucia Tricarico, Natale Daniele Brunetti

Summary: Alterations in endothelial function, inflammatory activation, and nitric oxide-cGMP pathway play a role in the pathophysiology of heart failure. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have emerged as potential treatments for heart failure, but their protective mechanisms are not fully understood.

HEART FAILURE REVIEWS (2023)

Article Cardiac & Cardiovascular Systems

Importance of Echocardiography and Clinical Red Flags in Guiding Genetic Screening for Fabry Disease

Rodolfo Citro, Costantina Prota, Donatella Ferraioli, Giuseppe Iuliano, Michele Bellino, Ilaria Radano, Angelo Silverio, Serena Migliarino, Maria Vincenza Polito, Artemisia Ruggiero, Rosa Napoletano, Vincenzo Bellizzi, Michele Ciccarelli, Gennaro Galasso, Carmine Vecchione

Summary: In a metropolitan area not previously investigated, the prevalence of Anderson-Fabry disease (FD) was found to be high (10%) among patients with left ventricular hypertrophy of unknown origin.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Biochemistry & Molecular Biology

SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency

Albino Carrizzo, Concetta Iside, Angela Nebbioso, Vincenzo Carafa, Antonio Damato, Sebastiano Sciarretta, Giacomo Frati, Flavio Di Nonno, Valentina Valenti, Michele Ciccarelli, Eleonora Venturini, Mariarosaria Scioli, Paola Di Pietro, Tommaso Bucci, Valentina Giudice, Marianna Storto, Bianca Serio, Annibale Alessandro Puca, Giuseppe Giugliano, Valentina Trimarco, Raffaele Izzo, Bruno Trimarco, Carmine Selleri, Lucia Altucci, Carmine Vecchione

Summary: In addition to well-known risk factors, cardiovascular events may also be associated with epigenetic and genetic alterations. This study found that the MTHFR C677T gene variant is related to increased cardiovascular risk. Interestingly, even with normal homocysteine levels, heterozygous carriers of this gene variant have an augmented risk of cardiovascular accidents, suggesting the presence of additional deregulated processes. The study suggests that targeting SIRT1 activation could be a new therapeutic strategy to control cardiovascular risk in MTHFR carriers.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Review Pharmacology & Pharmacy

Cardiovascular Implications of microRNAs in Coronavirus Disease 2019

Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli, Maria Rosaria Rusciano, Anna Laura Toni, Nicola Virtuoso, Albino Carrizzo, Paola Di Pietro, Guido Iaccarino, Carmine Vecchione, Michele Ciccarelli

Summary: The COVID-19 pandemic caused by SARS-CoV-2 is a global challenge, with cardiovascular involvement being a crucial complication. This report discusses the role of microRNAs in cardiovascular complications associated with COVID-19, highlighting their potential as biomarkers and predictors of cardiac and vascular damage.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

DOUBLE-CHAMBERED RIGHT VENTRICLE AND VENTRICULAR SEPTAL DEFECT IN AN ELDERLY WOMAN: A RARE CASE.

Mario Cristiano, Giuseppe Iuliano, Antonella Rispoli, Lucia Soriente, Michele Ciccarelli, Gennaro Galasso, Carmine Vecchione, Rodolfo Citro

EUROPEAN HEART JOURNAL SUPPLEMENTS (2022)

Review Biochemistry & Molecular Biology

The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers

Paola Di Pietro, Carmine Izzo, Angela Carmelita Abate, Paola Iesu, Maria Rosaria Rusciano, Eleonora Venturini, Valeria Visco, Eduardo Sommella, Michele Ciccarelli, Albino Carrizzo, Carmine Vecchione

Summary: Cardiovascular diseases (CVDs) are the leading cause of death and illness worldwide, accounting for 47% of deaths in Europe. Bioactive sphingolipids, including ceramides and sphingosine-1-phosphate (S1P), have been identified as drivers of CVDs. Monitoring sphingolipid levels could provide insights into the progression and severity of cardiovascular diseases and may be a potential target for therapeutic intervention.

BIOMOLECULES (2023)

Article Cardiac & Cardiovascular Systems

Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry

Giulia Elena Mandoli, Maria Concetta Pastore, Alberto Giannoni, Giovanni Benfari, Frank Lloyd Dini, Gianmarco Rosa, Nicola Riccardo Pugliese, Claudia Taddei, Michele Correale, Natale Daniele Brunetti, Pietro Mazzeo, Erberto Carluccio, Anna Mengoni, Andrea Igoren Guaricci, Laura Piscitelli, Rodolfo Citro, Michele Ciccarelli, Giuseppina Novo, Egle Corrado, Annalisa Pasquini, Valentina Loria, Giuseppe De Carli, Anna Degiovanni, Giuseppe Patti, Ciro Santoro, Luca Moderato, Mariantonietta Cicoira, Marco Canepa, Alessandro Malagoli, Michele Emdin, Matteo Cameli

Summary: Echocardiographic predictors, such as left atrial strain and global longitudinal strain, can help predict left ventricular reverse remodelling and clinical response in patients with heart failure and reduced ejection fraction (HFrEF) who are treated with Sacubitril/valsartan.

ESC HEART FAILURE (2023)

Review Medicine, General & Internal

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets

Angelo Silverio, Francesco Paolo Cancro, Luca Esposito, Michele Bellino, Debora D'Elia, Monica Verdoia, Maria Giovanna Vassallo, Michele Ciccarelli, Carmine Vecchione, Gennaro Galasso, Giuseppe De Luca

Summary: The control of cardiovascular risk factors, promotion of a healthy lifestyle, and antithrombotic therapy are important for secondary prevention after acute coronary syndrome (ACS). Identification of novel risk factors and targets is essential to optimize preventive strategies for patients who have recurrent ischemic events despite optimal control of traditional risk factors and pharmacological therapy.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study

Alessandro Mengozzi, Nicola Riccardo Pugliese, Giovambattista Desideri, Stefano Masi, Fabio Angeli, Carlo Maria Barbagallo, Michele Bombelli, Federica Cappelli, Edoardo Casiglia, Rosario Cianci, Michele Ciccarelli, Arrigo F. G. Cicero, Massimo Cirillo, Pietro Cirillo, Raffaella Dell'Oro, Lanfranco D'Elia, Claudio Ferri, Ferruccio Galletti, Loreto Gesualdo, Cristina Giannattasio, Guido Grassi, Guido Iaccarino, Luciano Lippa, Francesca Mallamaci, Alessandro Maloberti, Maria Masulli, Alberto Mazza, Maria Lorenza Muiesan, Pietro Nazzaro, Paolo Palatini, Gianfranco Parati, Roberto Pontremoli, Fosca Quarti-Trevano, Marcello Rattazzi, Gianpaolo Reboldi, Giulia Rivasi, Elisa Russo, Massimo Salvetti, Valerie Tikhonoff, Giuliano Tocci, Andrea Ungar, Paolo Verdecchia, Francesca Viazzi, Massimo Volpe, Claudio Borghi, Agostino Virdis

Summary: High serum uric acid (SUA) levels have been found to predict all-cause mortality (ACM) and cardiovascular mortality (CVM) in cardiometabolic patients without established cardiovascular disease, regardless of triglyceride (TG) levels. The study included 8124 patients from the URic acid Right for heArt Health (URRAH) study cohort, and the findings were confirmed by exploratory and sensitivity analyses. This suggests that SUA plays a substantial role in predicting cardiovascular risk in both normotriglyceridemia and hypertriglyceridemia.

METABOLITES (2023)

Article Biology

Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients

Alfonso Campanile, Valeria Visco, Stefania De Carlo, Germano Junior Ferruzzi, Costantino Mancusi, Carmine Izzo, Felice Mongiello, Paola Di Pietro, Nicola Virtuoso, Amelia Ravera, Domenico Bonadies, Carmine Vecchione, Michele Ciccarelli

Summary: This study compares the effects of Sac/Val and standard medical therapy on prognostically significant CPET parameters in HFrEF patients. After a median follow-up of 16 months, no significant differences were observed in peak VO2 and other CPET measures between Sac/Val and standard therapy.

LIFE-BASEL (2023)

Review Cardiac & Cardiovascular Systems

Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve

Valeria Visco, Carmine Izzo, Costantino Mancusi, Antonella Rispoli, Michele Tedeschi, Nicola Virtuoso, Angelo Giano, Renato Gioia, Americo Melfi, Bianca Serio, Maria Rosaria Rusciano, Paola Di Pietro, Alessia Bramanti, Gennaro Galasso, Gianni D'Angelo, Albino Carrizzo, Carmine Vecchione, Michele Ciccarelli

Summary: Arterial hypertension is a growing concern with the increasing aging population, and the potential of artificial intelligence in its prevention and treatment is well recognized. This article reviews the benefits of AI in managing hypertension, including personalized medicine and tailored treatment. However, the limitations and technical issues, such as biases and data privacy, should also be considered.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2023)

Review Medicine, General & Internal

Potential Role of Global Longitudinal Strain in Cardiac and Oncological Patients Undergoing Cardio-Oncology Rehabilitation (CORE)

Gianluigi Cuomo, Francesca Paola Iannone, Anna Di Lorenzo, Crescenzo Testa, Michele Ciccarelli, Elio Venturini, Arturo Cesaro, Mario Pacileo, Ercole Tagliamonte, Antonello D'Andrea, Carmine Vecchione, Carlo Vigorito, Francesco Giallauria

Summary: Although some cancer treatments are known to cause cardiotoxicity, cardiologists and oncologists have promoted the development of cardio-oncology to prevent cardiovascular disease in cancer patients. Cardio-oncology rehabilitation aims to improve symptoms, quality of life, cardiorespiratory fitness, and survival through risk factor correction, drug therapies, and exercise programs. Global longitudinal strain (GLS) has recently gained interest as an imaging modality for evaluating cardiac function in cancer patients undergoing rehabilitation programs.

CLINICS AND PRACTICE (2023)

Review Cardiac & Cardiovascular Systems

Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function

Michele Ciccarelli, Ines Falcao Pires, Johann Bauersachs, Luc Bertrand, Christophe Beauloye, Dana Dawson, Nazha Hamdani, Denise Hilfiker-Kleiner, Linda W. van Laake, Frank Lezoualc'h, Wolfgang A. Linke, Ida G. Lunde, Peter P. Rainer, Antonella Rispoli, Valeria Visco, Albino Carrizzo, Matteo Dal Ferro, Davide Stolfo, Jolanda van der Velden, Serena Zacchigna, Stephane Heymans, Thomas Thum, Carlo Gabriele Tocchetti

Summary: This scientific statement highlights the challenges in acute heart failure (AHF) treatment and emphasizes the need for research models and understanding of its mechanisms. It also discusses potential molecular targets for new therapeutic perspectives.

CARDIOVASCULAR RESEARCH (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Autoantibodies against the cardiovascular protective BPIFB4 in hospitalized patients with COVID-19

E. Ciaglia, F. Montella, V. Lopardo, R. M. Esposito, F. Guarracino, G. Spinetti, A. A. Maciag, M. Ciccarelli, C. Vitale, S. G. Pellegrino, B. Polverino, C. Izzo, C. Vecchione, A. A. Puca

EUROPEAN HEART JOURNAL (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes

L. Esposito, F. P. Cancro, A. Silverio, M. Di Maio, M. Bellino, S. Romei, M. Tedeschi, M. Ciccarelli, C. Vecchione, G. Galasso

EUROPEAN HEART JOURNAL (2022)

No Data Available